CompletedNCT04325659
Bridge Device and Medicines for Opioid Recovery
About this title
Read the official source — NCT04325659Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
What did participation involve?
After a period of morphine stabilization, the protocol assigns participants to one of three combinations: active Bridge Device with placebo (an inactive comparison treatment); simulated device with lofexidine; or simulated device with placebo. The device is used for five days and the study capsules for seven days.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: November 15, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 36
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- DEVICE, Medication / drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04325659
- Official title
Show the full official title
Evaluating a Neuromodulator Medical Device (Bridge Device) for Opioid Use Disorder Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedBaltimore
Questions about this study
What did participation involve?
The protocol called for participants to take study medication.
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Did this study involve medication?
Yes. The study involved medication, including Lofexidine and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
